CVE-2022-4989 ASUS CVE debrief

Who should care

Users of ASUS AI Suite 3 driver, operators of affected systems, platform administrators, vulnerability management teams, and security teams should review their systems for potential vulnerabilities and apply updates if available. They should also monitor system logs for suspicious IOCTL requests and implement compensating controls to limit local user access.

Technical summary

The ASUS AI Suite 3 driver has a vulnerability due to improper validation of specified quantity in input, allowing a local user to access unintended memory regions via crafted IOCTL requests, leading to privilege escalation. This vulnerability can be exploited by a local user with crafted IOCTL requests. The affected product is ASUS AI Suite 3 driver. The vulnerability has a high CVSS score of 8.5 and is classified as HIGH severity.

Defensive priority

High priority due to potential for local privilege escalation.

Recommended defensive actions

• Review and apply driver updates from ASUS.
• Monitor system logs for suspicious IOCTL requests.
• Implement compensating controls to limit local user access.
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up.
• Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance.
• Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed.
• Check relevant monitoring, detection, and logs for exposed assets that need extra review.

Evidence notes

The evidence for this CVE is limited; verification of vulnerability details and affected scope is needed. The ASUS AI Suite 3 driver has a vulnerability due to improper validation of specified quantity in input, allowing a local user to access unintended memory regions via crafted IOCTL requests, leading to privilege escalation. Defenders should verify the affected product deployments, review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance, and plan vendor-supported updates or mitigations through normal change control where exposure is confirmed.

Official resources